CLIP Ring
Status:
Phase:Pre-clinical
Principal Investigator(s):BENHABBOUR, SOUMYA RAHIMA
Objective:Islatravir Etonogestrel/Ethinyl Estradiol (EFdA) 3D Printed IVR
Our paramount innovation is use of digital light synthesis – a novel 3D printing process known as continuous liquid interface production (CLIP™) – for rapid, scalable, and cost-effective manufacturing of geometrically and mechanically tunable, rationally designed intravaginal rings as platforms for multi-drug delivery.Abstract presented at CROI 2022 See poster hereLast updated September 20, 2022
Prevention Option(s):Microbicides, MPTs
Study Design:
Arms and Assigned Interventions
DescriptionActive Ingredient:
Etonogestrel
Ethinyl Estradiol
Islatravir (EFdA)
Mode of DeliveryRing
ARMs
Official Code:
Islatravir (EFdA) + Etonogestrel/Ethinyl Estradiol 3D Printed IVR (http://www.mpts101.org/mpt-database/product-page/18-mpts/topical-mpts-rings/150-3d-printed-ivr-efda-etg-ee)
Trial Sponsors:
CDC, NIAID
Start Date
End Date
December 1, 2019
November 30, 2024
Enrollment:0
Age range:
↔
any
Population:Cisgender Men